September 13, 2007 - Alphatec Holdings Inc., a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, entered into an exclusive worldwide license for a unique vertebroplasty technology system that is focused on providing a solution for vertebral compression fractures.
The company’s wholly owned subsidiary, Alphatec Spine Inc. and Stout Medical Group LP entered into an exclusive license agreement that provides Alphatec Spine with a worldwide license to develop and commercialize Stout’s vertebroplasty technology system and implant called the V-Stent. The V-Stent is an expandable titanium cage that can be implanted minimally invasively into a vertebral body to treat compression fractures of the vertebral body. Stout, formed in early 2006, develops technologies for the orthopedics industry, specializing in spinal implants.
The exclusive license agreement expires in 2027.
For more information: www.alphatecspine.com